- Princeton NJ, US Eugene J. Schaefer - Westfield NJ, US Ronald Charles Bates - Irvine CA, US Elizabeth A. Bramhall - Groton MA, US David Michael Didio - Syracuse NY, US Robert Donaldson - Southborough MA, US Alan R. Flesher - Lawrenceville NJ, US Helen Gray Haggerty - Manlius NY, US David Henry Kirkley - East Syracuse NY, US John Malcolm Tabor - Syracuse NY, US Lee K. Tay - Princeton Junction NJ, US Pallaiah Thammana - Manlius NY, US Ajoy Velayudhan - Cary NC, US David Edward Smolin - Pennington NJ, US Reb J. Russell - Doylestown PA, US Thomas James Vanden Boom - Flemington NJ, US Dean Woodrow Brownell - Oswego NY, US Jeffrey Schrimsher - Hillsborough NC, US Joyce Patricia Whitehead - Manlius NY, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
C07K 14/705 A61K 38/19 C07K 16/28
Abstract:
The invention provides for mammalian cells capable of producing recombinant CTLA4-Ig and variants thereof. The invention also provides for compositions comprising CTLA4-Ig and formulations thereof. The invention further provides for methods for mass-producing CTLA4-Ig from mammalian cells capable of producing this recombinant protein, and for purifying the CTLA4-Ig.
- Princeton NJ, US Eugene J. Schaefer - Westfield NJ, US Ronald Charles Bates - Irvine CA, US Elizabeth A. Bramhall - Groton MA, US David Michael Didio - Syracuse NY, US Robert Donaldson - Southborough MA, US Alan R. Flesher - Lawrenceville NJ, US Helen Gray Haggerty - Manlius NY, US David Henry Kirkley - East Syracuse NY, US John Malcolm Tabor - Syracuse NY, US Lee K. Tay - Princeton Junction NJ, US Pallaiah Thammana - Manlius NY, US Ajoy Velayudhan - Cary NC, US David Edward Smolin - Pennington NJ, US Reb J. Russell - Doylestown PA, US Thomas James Vanden Boom - Flemington NJ, US Dean Woodrow Brownell - Oswego NY, US Jeffrey Schrimsher - Hillsborough NC, US Joyce Patricia Whitehead - Manlius NY, US
The invention provides for mammalian cells capable of producing recombinant CTLA4-Ig and variants thereof. The invention also provides for compositions comprising CTLA4-Ig and formulations thereof The invention further provides for methods for mass-producing CTLA4-Ig from mammalian cells capable of producing this recombinant protein, and for purifying the CTLA4-Ig.
Compositions And Methods For Producing A Composition
- Princeton NJ, US Eugene J. Schaefer - Westfield NJ, US Ronald Charles Bates - Irvine CA, US Elizabeth A. Bramhall - Groton MA, US David Michael Didio - Syracuse NY, US Robert Donaldson - Southborough MA, US Alan R. Flesher - Lawrenceville NJ, US Helen Gray Haggerty - Manlius NY, US David Henry Kirkley - East Syracuse NY, US John Malcolm Tabor - Syracuse NY, US Lee K. Tay - Princeton Junction NJ, US Pallaiah Thammana - Manlius NY, US Ajoy Velayudhan - Cary NC, US David Edward Smolin - Pennington NJ, US Reb J. Russell - Doylestown PA, US Thomas James Vanden Boom - Flemington NJ, US Dean Woodrow Brownell - Oswego NY, US Jeffrey Schrimsher - Hillsborough NC, US Joyce Patricia Whitehead - Manlius NY, US
The invention provides for mammalian cells capable of producing recombinant CTLA4-Ig and variants thereof. The invention also provides for compositions comprising CTLA4-Ig and formulations thereof. The invention further provides for methods for mass-producing CTLA4-Ig from mammalian cells capable of producing this recombinant protein, and for purifying the CTLA4-Ig.
- Princeton NJ, US Eugene J. Schaefer - Westfield NJ, US Ronald Charles Bates - Irvine CA, US Elizabeth A. Bramhall - Groton MA, US David Michael Didio - Syracuse NY, US Robert Donaldson - Southborough MA, US Alan R. Flesher - Lawrenceville NJ, US Helen Gray Haggerty - Manlius NY, US David Henry Kirkley - East Syracuse NY, US John Malcolm Tabor - Syracuse NY, US Lee K. Tay - Princeton Junction NJ, US Pallaiah Thammana - Manlius NY, US Ajoy Velayudhan - Cary NC, US David Edward Smolin - Pennington NJ, US Reb J. Russell - Doylestown PA, US Thomas James Vanden Boom - Flemington NJ, US Dean Woodrow Brownell - Oswego NY, US Jeffrey Schrimsher - Hillsborough NC, US Joyce Patricia Whitehead - Manlius NY, US
The invention provides for mammalian cells capable of producing recombinant CTLA4-Ig and variants thereof. The invention also provides for compositions comprising CTLA4-Ig and formulations thereof. The invention further provides for methods for mass-producing CTLA4-Ig from mammalian cells capable of producing this recombinant protein, and for purifying the CTLA4-Ig.